Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Davis

Showing results (151-160 of 205) with videos related to

Pageof 21
Sort By:
The Journal of Pediatrics|January 29, 2020
Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence SyndromeAdam J Czynski, Jonathan M Davis, Lynne M Dansereau, et al.
BMJ (Clinical Research Ed.)|August 4, 2017
Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort studyKrista F Huybrechts, Brian T Bateman, Rishi J Desai, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28-29, 2014Martin Offringa, Jonathan M Davis, Mark A Turner, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 13, 2002
Distinct patterns of apoptosis in the lung during liquid ventilation compared with gas ventilationLin L Mantell, Thomas H Shaffer, Stuart Horowitz, et al.
Trials|November 9, 2016
A core outcome set for neonatal abstinence syndrome: study protocol for a systematic review, parent interviews and a Delphi surveyLauren E Kelly, Lauren M Jansson, Wendy Moulsdale, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Maternal Opioids Downregulate Adiponectin Receptor Signaling and Alter Growth in Offspring: Pilot StudyElizabeth Yen, Kiran Singh, Marissa Chow, et al.
The Journal of Pediatrics|June 26, 2019
Necrotizing Enterocolitis: Using Regulatory Science and Drug Development to Improve OutcomesMichael S Caplan, Mark A Underwood, Neena Modi, et al.
Therapeutic Innovation & Regulatory Science|April 26, 2022
Global Regulatory and Public Health Initiatives to Advance Pediatric Drug Development for Rare DiseasesCarla Epps, Ralph Bax, Alysha Croker, et al.
The Journal of Biological Chemistry|September 7, 2002
Suppression of nuclear factor-kappa B activity by nitric oxide and hyperoxia in oxygen-resistant cellsWilliam R Franek, Yalamanchali C Chowdary, Xinchun Lin, et al.
Frontiers in Pediatrics|April 17, 2026
Maternal opioids downregulate adiponectin receptor signaling and alter growth in offspring: pilot studyElizabeth Yen, Kiran Singh, Marissa Chow, et al.
Pageof 21

Showing results (151-160 of 205) with videos related to

Sort By:
Pageof 21
The Journal of Pediatrics|January 29, 2020
Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence SyndromeAdam J Czynski, Jonathan M Davis, Lynne M Dansereau, et al.
BMJ (Clinical Research Ed.)|August 4, 2017
Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort studyKrista F Huybrechts, Brian T Bateman, Rishi J Desai, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28-29, 2014Martin Offringa, Jonathan M Davis, Mark A Turner, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 13, 2002
Distinct patterns of apoptosis in the lung during liquid ventilation compared with gas ventilationLin L Mantell, Thomas H Shaffer, Stuart Horowitz, et al.
Trials|November 9, 2016
A core outcome set for neonatal abstinence syndrome: study protocol for a systematic review, parent interviews and a Delphi surveyLauren E Kelly, Lauren M Jansson, Wendy Moulsdale, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Maternal Opioids Downregulate Adiponectin Receptor Signaling and Alter Growth in Offspring: Pilot StudyElizabeth Yen, Kiran Singh, Marissa Chow, et al.
The Journal of Pediatrics|June 26, 2019
Necrotizing Enterocolitis: Using Regulatory Science and Drug Development to Improve OutcomesMichael S Caplan, Mark A Underwood, Neena Modi, et al.
Therapeutic Innovation & Regulatory Science|April 26, 2022
Global Regulatory and Public Health Initiatives to Advance Pediatric Drug Development for Rare DiseasesCarla Epps, Ralph Bax, Alysha Croker, et al.
The Journal of Biological Chemistry|September 7, 2002
Suppression of nuclear factor-kappa B activity by nitric oxide and hyperoxia in oxygen-resistant cellsWilliam R Franek, Yalamanchali C Chowdary, Xinchun Lin, et al.
Frontiers in Pediatrics|April 17, 2026
Maternal opioids downregulate adiponectin receptor signaling and alter growth in offspring: pilot studyElizabeth Yen, Kiran Singh, Marissa Chow, et al.
Pageof 21